ClinConnect ClinConnect Logo
Search / Trial NCT06104124

A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Launched by AMGEN · Oct 23, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Sjögren's Syndrome With Moderate To Severe Systemic Disease Activity Study Phase: Phase 3 European Alliance Of Associations For Rheumatology Sjögren's Syndrome Disease Activity Index (Essdai) European Alliance Of Associations For Rheumatology Sjögren's Syndrome Patient Reported Index (Esspri) European Alliance Of Associations For Rheumatology (Eular)

ClinConnect Summary

This clinical trial is studying a new medication called dazodalibep to see how well it works for people with Sjögren's syndrome (SS), especially those who have moderate to severe symptoms affecting their overall health. The main goal is to find out if dazodalibep can improve the symptoms of SS that affect the body as a whole, as well as to hear directly from patients about how they feel while taking this medication. Additionally, the study will monitor the safety of dazodalibep to ensure it can be tolerated by participants.

To be eligible for this trial, participants must be diagnosed with Sjögren's syndrome according to specific guidelines and show a certain level of disease activity despite other treatments. They should also test positive for specific autoantibodies. However, individuals with certain serious health conditions, like recent blood clots or certain cancers, will not be able to participate. Those who join the study can expect regular check-ins to assess their health and how they respond to the treatment. This trial is currently looking for volunteers of all genders, aged 65 to 74.

Gender

ALL

Eligibility criteria

  • Key Inclusion Criteria:
  • Diagnosed with Sjögren's syndrome (SS) by meeting the 2016 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) Classification Criteria.
  • Have an European Alliance of Associations for Rheumatology Sjögren's Syndrome Disease Activity Index (ESSDAI) score of \>= 5 despite symptomatic or local therapy at screening.
  • Positive for either anti-Ro autoantibodies or rheumatoid factor (RF), or both at screening (as per the central laboratory test).
  • Key Exclusion Criteria:
  • Medical history of confirmed deep vein thrombosis, pulmonary embolism, or arterial thromboembolism within 2 years of screening.
  • Active malignancy or history of malignancy within the last 5 years, except in situ carcinoma of cervix treated with apparent success with curative therapy \> 12 months prior to screening OR cutaneous basal cell carcinoma following presumed curative therapy.
  • Individuals with any severe or life-threatening cardiovascular (including vasculitis), respiratory, endocrine, gastrointestinal, hematological, psychiatric, or systemic disorder or any other condition that would place the individual at unacceptable risk of complications, interfere with evaluation of the IP, or confound the interpretation of participant safety or study results.
  • Individuals who have a positive test for hepatitis B, hepatitis C, or HIV infection. A positive test for hepatitis B at screening is defined as: (1) positive for HBsAg OR (2) positive for either HBcAb or HBsAb and HBV DNA detected above the LLOQ by reflex testing by the central laboratory at screening.
  • Active TB or untreated (per local guidelines) latent TB
  • Individuals with a history of more than one episode of herpes zoster and/or any opportunistic infection in the last 12 months, and active infection requiring systemic treatment at the time of screening or through randomization, or history of more than 2 infections requiring intravenous (IV) antibiotics within 12 months prior to screening.
  • Individuals who have received a live (attenuated) vaccine within the 4 weeks prior to randomization or plan to receive a live vaccine during their participation in the study.
  • Last administration of experimental or investigational biologic or oral agents \< 6 months prior to screening.
  • Individuals who have had previous treatment with any biologic B-cell-depleting therapy (eg, rituximab, ocrelizumab, inebilizumab, ofatumumab, or ianalumab) within 12 months or other B-cell-targeting therapy (eg, belimumab) \< 3 months prior to screening.

About Amgen

Amgen is a leading global biotechnology company dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. With a strong focus on areas such as oncology, cardiovascular disease, and inflammation, Amgen leverages advanced science and technology to address complex medical needs. The company is committed to improving patient outcomes through rigorous clinical trials and robust research initiatives, ensuring the highest standards of safety and efficacy in its products. With a rich pipeline of cutting-edge therapies, Amgen continues to be at the forefront of biopharmaceutical advancements, making a significant impact on healthcare worldwide.

Locations

Boston, Massachusetts, United States

Madrid, , Spain

Newcastle Upon Tyne, , United Kingdom

Woodville South, South Australia, Australia

Santa Cruz De Tenerife, , Spain

Taichung, , Taiwan

Sevilla, , Spain

Shinjuku Ku, Tokyo, Japan

Sevilla, , Spain

Tamarac, Florida, United States

Curitiba, Paraná, Brazil

Gwangju, , Korea, Republic Of

Leeds, , United Kingdom

Bunkyo Ku, Tokyo, Japan

Belgrade, , Serbia

Kansas City, Kansas, United States

Maribor, , Slovenia

Novi Sad, , Serbia

Heidelberg, , Germany

Charlotte, North Carolina, United States

Madrid, , Spain

Ljubljana, , Slovenia

Bydgoszcz, , Poland

Nottingham, , United Kingdom

A Coruña, , Spain

Valencia, , Spain

Verona, , Italy

Novi Sad, , Serbia

Strasbourg, , France

Seoul, , Korea, Republic Of

Sapporo Shi, , Japan

Kyoto Shi, , Japan

Elblag, , Poland

Mexico, , Mexico

Sevilla, , Spain

Gent, Oost Vlaanderen, Belgium

Porto Alegre, Rio Grande Do Sul, Brazil

Leuven, Vlaams Brabant, Belgium

Taipei, , Taiwan

Osijek, , Croatia

Cordoba, , Spain

Iruma Gun, Saitama, Japan

Kragujevac, , Serbia

Torino, Piemonte, Italy

Hamburg, , Germany

London, , United Kingdom

Meguro Ku, Tokyo, Japan

Nagasaki Shi, Nagasaki, Japan

Guadalajara, Jalisco, Mexico

Poznan, Wielkopolskie, Poland

Kyoto Shi, , Japan

Juiz De Fora, Minas Gerais, Brazil

Milano, Lombardia, Italy

Merida, Yucatán, Mexico

Cordoba, Córdoba, Spain

Tomball, Texas, United States

Firenze, Toscana, Italy

Sabadell, Barcelona, Spain

Salvador, Bahia, Brazil

Madrid, , Spain

Kurashiki Shi, Okayama, Japan

Tsukuba Shi, Ibaraki, Japan

Mexico, , Mexico

Wroclaw, Dolnoslaskie, Poland

Le Kremlin Bicêtre, , France

Bydgoszcz, , Poland

Quilmes, Buenos Aires, Argentina

Bilbao, , Spain

Ciudad Autónoma De Buenos Aires, , Argentina

Kfar Sava, Hamerkaz, Israel

Suwon Si, , Korea, Republic Of

Clearwater, Florida, United States

Szczecin, Zachodniopomorskie, Poland

Mexicali, Baja California, Mexico

Sapporo Shi, Hokkaidô, Japan

Roma, Lazio, Italy

Bordeaux, , France

Lublin, Lubelskie, Poland

Nishinomiya Shi, , Japan

Jerusalem, Yerushalayim, Israel

Skórzewo, Wielkopolskie, Poland

West Valley City, Utah, United States

Roma, Lazio, Italy

Itabashi, Tokyo, Japan

Udine, Friuli Venezia Giulia, Italy

Warszawa, Mazowieckie, Poland

La Plata, Buenos Aires, Argentina

Rosario, Santa Fe, Argentina

Porto Alegre, Rio Grande Do Sul, Brazil

Gyula, , Hungary

Katowice, , Poland

San Miguel Chapultepec, Distrito Federal, Mexico

Merida, , Mexico

Athina, Attiki, Greece

Warszawa, Mazowieckie, Poland

Heidelberg, Baden Württemberg, Germany

Viña Del Mar, Valparaíso, Chile

Kraków, Malopolskie, Poland

łódź, , Poland

Luton, Bedfordshire, United Kingdom

Monterrey, , Mexico

Beverly Hills, California, United States

Upland, California, United States

Denver, Colorado, United States

Bradenton, Florida, United States

Saint Clair Shores, Michigan, United States

Voorhees, New Jersey, United States

Amarillo, Texas, United States

Baytown, Texas, United States

Chuo Ku, Tokyo, Japan

Mitras Centro, , Mexico

Nishinomiya Shi, Hyôgo, Japan

Yokohama Shi, Kanagawa, Japan

Auckland, , New Zealand

Chandler, Arizona, United States

Flagstaff, Arizona, United States

Fort Collins, Colorado, United States

Voorhees, New Jersey, United States

Dayton, Ohio, United States

Bothell, Washington, United States

Bothell, Washington, United States

Chandler, Arizona, United States

Flagstaff, Arizona, United States

Gilbert, Arizona, United States

Glendale, Arizona, United States

Tucson, Arizona, United States

Fort Collins, Colorado, United States

New Port Richey, Florida, United States

Tamarac, Florida, United States

Miamisburg, Ohio, United States

Vandalia, Ohio, United States

Mcallen, Texas, United States

Tomball, Texas, United States

Voorhees, New Jersey, United States

Novara, Piemonte, Italy

Boston, Massachusetts, United States

Kansas City, Missouri, United States

Salisbury, North Carolina, United States

Katy, Texas, United States

Ciudad Autonoma De Buenos Aires, , Argentina

Trois Rivières, Quebec, Canada

Kurashiki Shi, Okayama, Japan

Gwangju, Gwangju Gwang'yeogsi, Korea, Republic Of

Namdong Gu, , Korea, Republic Of

Jackson, Tennessee, United States

San Miguel De Tucumán, Tucumán, Argentina

San Miguel De Tucumán, Tucumán, Argentina

Debrecen, Hajdú Bihar, Hungary

Flagstaff, Arizona, United States

Gilbert, Arizona, United States

Glendale, Arizona, United States

Tucson, Arizona, United States

Beckley, West Virginia, United States

Fort Collins, Colorado, United States

Boston, Massachusetts, United States

Baytown, Texas, United States

Grapevine, Texas, United States

Katy, Texas, United States

Ciudad Autónoma De Buenos Aires, Buenos Aires, Argentina

Nagoya Shi, Aiti, Japan

Sasebo Shi, Nagasaki, Japan

Hamamatsu City, Sizuoka, Japan

Tomball, Texas, United States

San Miguel De Tucumán, Tucumán, Argentina

Thessaloniki, , Greece

Belgrade, , Serbia

Nagoya Shi, Aiti, Japan

Malaga, , Spain

Zagreb, Grad Zagreb, Croatia

Pisa, Toscana, Italy

Ciudad Autónoma De Buenos Aires, Ciudad Autónoma De Buenosaires, Argentina

Ciudad Autónoma De Buenos Aires, Ciudad Autónoma De Buenosaires, Argentina

San Miguel De Tucuman, Tucumán, Argentina

Sapporo Shi, Hokkaidô, Japan

Quilmes, Buenos Aires, Argentina

Catania, Sicilia, Italy

Athina, Attiki, Greece

Belgrade, , Serbia

Warszawa, Mazowieckie, Poland

Warszawa, Mazowieckie, Poland

Poznań, Wielkopolskie, Poland

Denver, Colorado, United States

Salisbury, North Carolina, United States

Nagoya, Aiti, Japan

Kita Kyushu Shi, Hukuoka, Japan

Kahoku Shi, Isikawa, Japan

Kyoto Shi, Kyôto, Japan

Kyoto Shi, Kyôto, Japan

Santa Coloma De Gramenet(barcelona), , Spain

Ormond Beach, Florida, United States

Voula, Attiki, Greece

Hamilton, , New Zealand

Vila Nova De Gaia, , Portugal

San Juan, , Puerto Rico

Zagreb, Grad Zagreb, Croatia

Kanazawa Shi, Isikawa, Japan

Houston, Texas, United States

San Antonio, Texas, United States

Temuco, Araucanía, Chile

Santiago, Región Metropolitanadesantiago, Chile

Fort Collins, Colorado, United States

Buenos Aires, , Argentina

Split, , Croatia

Bad Doberan, Mecklenburg Vorpommern, Germany

Alessandria, Piemonte, Italy

Toledo, Ohio, United States

Chemnitz, , Germany

Larissa, Larisa, Greece

Hódmezővásárhely, Csongrád, Hungary

Lublin, Lubelskie, Poland

Malbork, Pomorskie, Poland

Wrocław, , Poland

Lisboa, , Portugal

Ciudad Autónoma De Buenos Aires, Ciudad Autónoma De Buenosaires, Argentina

La Jolla, California, United States

Miami, Florida, United States

Tampa, Florida, United States

Rockford, Illinois, United States

Brooklyn, New York, United States

Miamisburg, Ohio, United States

Katy, Texas, United States

Bothell, Washington, United States

Ciudad Autónoma De Buenos Aires, Buenos Aires, Argentina

Ciudad Autónoma De Buenos Aires, Buenos Aires, Argentina

Ciudad Autónoma De Buenos Aires, Ciudad Autónoma De Buenosaires, Argentina

Recoleta, Ciudad Autónoma De Buenosaires, Argentina

Ciudad De Cordoba, Córdoba, Argentina

San Juan, , Argentina

Belo Horizonte, Minas Gerais, Brazil

Trois Rivieres, Quebec, Canada

Valdivia, Los Ríos, Chile

Providencia, Región Metropolitanadesantiago, Chile

Santiago, Región Metropolitanadesantiago, Chile

Zagreb, Grad Zagreb, Croatia

Mulhouse, Haut Rhin, France

Brest, , France

Paris, , France

Jerusalem, Yerushalayim, Israel

Ramat Gan, , Israel

Milano, Lombardia, Italy

Ciudad De México, Distrito Federal, Mexico

Oaxaca, , Mexico

Auckland, , New Zealand

Trujillo, La Libertad, Peru

Lima, , Peru

Pueblo Libre, , Peru

Wrocław, Dolnoslaskie, Poland

Warszawa, Mazowieckie, Poland

Warszawa, Mazowieckie, Poland

Wołomin, Mazowieckie, Poland

Kraków, , Poland

Warszawa, , Poland

Wroclaw, , Poland

Wrocław, , Poland

Lisbon, Lisboa, Portugal

Ponte De Lima, Viana Do Castelo, Portugal

Vitoria, álava, Spain

Gui Shan Qu, , Taiwan

Kaohsiung City, , Taiwan

Poznan, Wielkopolskie, Poland

Budapest, , Hungary

Lima, , Peru

Lima, , Peru

Lima, , Peru

Portsmouth, , United Kingdom

Durham, North Carolina, United States

Greifswald Hansestadt, Mecklenburg Vorpommern, Germany

Gyula, Békés, Hungary

Reggio Emilia, Emilia Romagna, Italy

Guadalajara, Jalisco, Mexico

Elblag, , Poland

Ciudad Autónoma De Buenos Aires, Ciudad Autónoma De Buenosaires, Argentina

Parques De San Felipe, Chihuahua, Mexico

Arequipa, , Peru

London, Camden, United Kingdom

Ciudad Autónoma De Buenos Aires, , Argentina

Murfreesboro, Tennessee, United States

Zagreb, Grad Zagreb, Croatia

Torreón Centro, Coahuila, Mexico

Phoenix, Arizona, United States

Augusta, Georgia, United States

Vina Del Mar, Valparaíso, Chile

Odense C, South Denmark, Denmark

Roma, Lazio, Italy

Poznań, , Poland

Wrocław, , Poland

San Juan De Lurigancho, Lima, Peru

Warszawa, Mazowieckie, Poland

Poznan, Wielkopolskie, Poland

Santa Cruz De Tenerife., , Spain

San Fernando, Buenos Aires, Argentina

Phoenix, Arizona, United States

Saltillo, Coahuila, Mexico

Austin, Texas, United States

Bellevue, Washington, United States

Leon, , Mexico

Castellón, , Spain

Ciudad Autónoma De Buenos Aires, , Argentina

Saint Priest En Jarez, Loire, France

Kraków, , Poland

Warszawa, , Poland

Avondale, Arizona, United States

Coral Gables, Florida, United States

Las Vegas, Nevada, United States

Salisbury, North Carolina, United States

Summerville, South Carolina, United States

Budapest, , Hungary

Civitavecchia Rm, , Italy

Lublin, Lubelskie, Poland

Poznan, Wielkopolskie, Poland

Malaga, Málaga, Spain

Taipei, , Taiwan

Patra, Achaïa, Greece

Seoul, , Korea, Republic Of

Valdivia, , Chile

Debrecen, , Hungary

Curitiba, , Brazil

Ciudad Autónoma De Buenos Aires, , Argentina

Ciudad De Cordoba, , Argentina

San Miguel De Tucuman, , Argentina

San Miguel De Tucumán, , Argentina

San Miguel De Tucumán, , Argentina

Sapporo Shi, , Japan

Boston, Massachusetts, United States

Ciudad Autónoma De Buenos Aires, , Argentina

Ciudad Autónoma De Buenos Aires, , Argentina

Brasília, Distrito Federal, Brazil

Temuco, , Chile

Providencia, , Chile

Santiago, , Chile

Vina Del Mar, , Chile

Patra, , Greece

Hódmezővásárhely, , Hungary

Poznań, , Poland

Vitoria, , Spain

Luton, Bedfordshire, United Kingdom

London, Camden, United Kingdom

Leeds, , United Kingdom

London, , United Kingdom

Kato Sychena Patras, , Greece

Patients applied

0 patients applied

Trial Officials

MD

Study Director

Amgen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported